LOC441089 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 4.894600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
5.395800E-01
Normal-vs-Stage2
3.512600E-01
Normal-vs-Stage3
2.487400E-01
Normal-vs-Stage4
6.720800E-01
Stage1-vs-Stage2
8.411400E-01
Stage1-vs-Stage3
4.059600E-01
Stage1-vs-Stage4
9.006400E-01
Stage2-vs-Stage3
3.476400E-01
Stage2-vs-Stage4
7.386200E-01
Stage3-vs-Stage4
4.185600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
4.794600E-01
Normal-vs-AfricanAmerican
4.935800E-01
Normal-vs-Asian
6.612600E-01
Caucasian-vs-AfricanAmerican
8.505400E-01
Caucasian-vs-Asian
7.599600E-01
AfricanAmerican-vs-Asian
7.516800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
3.697200E-01
Normal-vs-Female
6.550600E-01
Male-vs-Female
1.382380E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
4.739800E-01
Normal-vs-Age(41-60Yrs)
8.336400E-01
Normal-vs-Age(61-80Yrs)
3.749000E-01
Normal-vs-Age(81-100Yrs)
3.103400E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
5.472000E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
9.284600E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
9.621800E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
1.613850E-02
Age(41-60Yrs)-vs-Age(81-100Yrs)
2.219800E-01
Age(61-80Yrs)-vs-Age(81-100Yrs)
9.141400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
2.777200E-01
Normal-vs-Daily Drinker
1.527590E-01
Normal-vs-Weekly Drinker
4.399800E-01
Normal-vs-Occasional Drinker
9.679200E-01
Normal-vs-Social Drinker
8.583200E-01
Non Drinker-vs-Daily Drinker
7.570600E-01
Non Drinker-vs-Weekly Drinker
5.812600E-01
Non Drinker-vs-Occasional Drinker
7.092300E-02
Non Drinker-vs-Social Drinker
1.323840E-01
Daily Drinker-vs-Weekly Drinker
6.868600E-01
Daily Drinker-vs-Occasional Drinker
1.148640E-01
Daily Drinker-vs-Social Drinker
2.007400E-01
Weekly Drinker-vs-Occasional Drinker
2.957400E-01
Weekly Drinker-vs-Social Drinker
4.074000E-01
Occasional Drinker-vs-Social Drinker
8.194400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
7.535200E-01
Normal-vs-Grade 2
8.663200E-01
Normal-vs-Grade 3
8.940000E-01
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
8.560600E-01
Grade 1-vs-Grade 3
9.075600E-01
Grade 1-vs-Grade 4
7.535200E-01
Grade 2-vs-Grade 3
5.763200E-01
Grade 2-vs-Grade 4
8.663200E-01
Grade 3-vs-Grade 4
8.940000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
1.811450E-01
Normal-vs-NonDiabetic
5.345200E-01
Diabetic-vs-NonDiabetic
1.009010E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
5.132400E-02
Normal-vs-NoPancreatitis
5.048000E-01
Pancreatitis-vs-NoPancreatitis
3.267500E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
7.304800E-01
Normal-vs-N1
3.591600E-01
N0-vs-N1
2.872400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
4.723800E-01
Normal-vs-TP53-NonMutant
5.839000E-01
TP53-Mutant-vs-TP53-NonMutant
9.000200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
